C-SRC PROTO-ONCOGENE PRODUCT IN NEURONS

Information

  • Research Project
  • 3191288
  • ApplicationId
    3191288
  • Core Project Number
    R01CA047572
  • Full Project Number
    7R01CA047572-05
  • Serial Number
    47572
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/1/1988 - 37 years ago
  • Project End Date
    6/30/1993 - 31 years ago
  • Program Officer Name
  • Budget Start Date
    9/30/1992 - 32 years ago
  • Budget End Date
    6/30/1993 - 31 years ago
  • Fiscal Year
    1992
  • Support Year
    5
  • Suffix
  • Award Notice Date
    9/18/1992 - 32 years ago

C-SRC PROTO-ONCOGENE PRODUCT IN NEURONS

The cellular src gene product displays a unique pattern of expression in neuronal cells that differs qualitatively and quantitatively from that found in other cell (designated pp60 c- src(+)) which contains a 6-amino acid insert within the amino- terminal region of the protein. This insert appears to be a consequence of a unique pattern of c-src mRNA splicing in neurons since c-src cDNA clones isolated from chicken and mouse brain cDNA libraries contain an 18-nucleotide insert located between the exons 3 and 4. The finding that neurons specifically express high levels of an altered form of pp60 c-src, and the evidence that tyrosine kinases are involved in pp60 c-src may play a role in regulating neuronal cell function. This proposal describes plans to further characterize the functional activity of this unique form of pp60 c-src and its localization in neural tissues. We also will examine how expression to isolate and characterize cellular proteins that might interact with pp60 c-src(4) to regulate its functional activity. These experiments should provide clues to the function of pp60 c-src which serves as a model protein for the src-family of proto-oncogene products that are associated exclusively with the cytoplasmic face of he plasma membrane, and thus cannot function directly as receptors for peptide hormones.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R01
  • Administering IC
    CA
  • Application Type
    7
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    396
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    CBY
  • Study Section Name
    Cellular Biology and Physiology Subcommittee 1
  • Organization Name
    ARIAD PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02139
  • Organization District
    UNITED STATES